SCHEMBL20126411

SCHEMBL20126411

CC[C@@H](C)[C@H]1OC(=O)[C@H](C)[C@H]1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25633775 1.00 — —
SCHEMBL25633774 0.96 — —
SCHEMBL13120133 0.87 HIF1A (0.35) —
SCHEMBL13105443 0.87 HIF1A (0.35) —
SCHEMBL20009694 0.82 HIF1A (0.39) —
SCHEMBL25633777 0.80 — —
SCHEMBL14428823 0.79 HIF1A (0.33) —
SCHEMBL10110534 0.78 MEN1 (0.31) —
SCHEMBL12833579 0.74 HIF1A (0.34) —
SCHEMBL13355731 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180127343-A1 NOVEL COMPOUNDS FOR TREATING DIABETES THE CHINESE UNIVERSITY OF HONG KONG (CN) 2018-05-10 — — US disclosed
Send feedback